HELIUM and ECZEMA

2 reports of this reaction

1.6% of all HELIUM reports

#17 most reported adverse reaction

Overview

ECZEMA is the #17 most commonly reported adverse reaction for HELIUM, manufactured by A-OX Welding Supply, LLC. There are 2 FDA adverse event reports linking HELIUM to ECZEMA. This represents approximately 1.6% of all 129 adverse event reports for this drug.

Patients taking HELIUM who experience eczema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ECZEMA2 of 129 reports

ECZEMA is a less commonly reported adverse event for HELIUM, but still significant enough to appear in the safety profile.

Other Side Effects of HELIUM

In addition to eczema, the following adverse reactions have been reported for HELIUM:

Other Drugs Associated with ECZEMA

The following drugs have also been linked to eczema in FDA adverse event reports:

CRISABOROLEDIPHENHYDRAMINE HCL, ZINC ACETATEDUPILUMABFERRUM PHOSPHORICUM

Frequently Asked Questions

Does HELIUM cause ECZEMA?

ECZEMA has been reported as an adverse event in 2 FDA reports for HELIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ECZEMA with HELIUM?

ECZEMA accounts for approximately 1.6% of all adverse event reports for HELIUM, making it a notable side effect.

What should I do if I experience ECZEMA while taking HELIUM?

If you experience eczema while taking HELIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

HELIUM Full ProfileAll Drugs Causing ECZEMAA-OX Welding Supply, LLC Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.